Spotlight On... Apple launches CareKit with four iPhone apps to start; Micro-cap Dahaier gets $20M strategic investment; PavMed squeezes out $5.3M IPO; and more...

Apple's ($AAPL) CareKit, which is aimed at helping patients better track their own health, was announced last month. Now it's started rolling out. And four iPhone apps are integrated with it already: two Glow apps, one that tracks an infant's symptoms and the other that sends that information to a pediatrician; the Start app for monitoring depression medication adherence; and One Drop, a diabetes app to track glucose, food, insulin and activity. More

@FierceMedDev: JAMA: Adding 3-D mammography decreases patient recalls, increases cancer detection. More | Follow @FierceMedDev

@EmilyWFierce: Teva enlists House M.D. actress to amp up migraine awareness. FiercePharmaMarketing story | Follow @EmilyWFierce

@amirahalidrus Transatlantic team reverses Alzheimer's, Parkinson's symptoms in fruit flies. FierceBiotechResearch story | Follow @amirahalidrus

> Chinese respiratory product maker Dehaier Medical Systems ($DHRM) has received a $20 million strategic investment from mobile and Internet services provider Liaison Interactive. This is particularly notable since this financing is in excess of its current market cap. More

> New York, NY-based medical device player PavMed ($PAVMU) got a tiny IPO done for $5.3 million. It has a pipeline of 5 medical devices including a self-anchoring catheter and a long-term implantable vascular access device. Its unit price more than doubled in early trading to $12 from $5. More

> AtriCure ($ATRC) has raised a $25 million five-year term loan and renewed a $15 million revolving line of credit with Silicon Valley Bank. More

Suggested Articles

Grail published new data showing that its cancer-screening blood test is now able to spot more than 50 types of the disease and across all stages.

Battelle received an emergency go-ahead from the FDA over the weekend to deploy its decontamination system for N95 respirator masks.

The limited supply of ventilators is one of the chief concerns facing hospitals as they prepare for more COVID-19 cases.